强效抗血小板药物姜二酮衍生物的合成

Y. Lai, L. J. Huang, Hsien‐Cheng Lin, Tian-Shung Wu, C. Teng, S. Kuo
{"title":"强效抗血小板药物姜二酮衍生物的合成","authors":"Y. Lai, L. J. Huang, Hsien‐Cheng Lin, Tian-Shung Wu, C. Teng, S. Kuo","doi":"10.7019/CPJ.200208.0259","DOIUrl":null,"url":null,"abstract":"In search of novel antiplatelet agents, the naturally-occurring gingerdiones (20, 24) were selected as lead com pounds. A series of their derivatives were synthesized and screened for anti-platelet activity. It was found that all of the synthesized gingerdione derivatives demonstrated potent inhibition against AA-induced platelet aggregation. Among them, 141-gingerdione (I8) and 51-gingerdione (19) showed the highest potency, being about 1/3 and one time as potent as indomethacin, respectively. Preliminary studies indicated that the mechanism of action of these gingerdione derivatives differed from indomethacin. Unlike indomethacin, they showed no appreciable COX-I and COX-2 inhibition. The exact mechanism of action of these new compounds","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"55 1","pages":"259-269"},"PeriodicalIF":0.0000,"publicationDate":"2002-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Synthesis of Gingerdione Derivatives as Potent Antiplatelet Agents\",\"authors\":\"Y. Lai, L. J. Huang, Hsien‐Cheng Lin, Tian-Shung Wu, C. Teng, S. Kuo\",\"doi\":\"10.7019/CPJ.200208.0259\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In search of novel antiplatelet agents, the naturally-occurring gingerdiones (20, 24) were selected as lead com pounds. A series of their derivatives were synthesized and screened for anti-platelet activity. It was found that all of the synthesized gingerdione derivatives demonstrated potent inhibition against AA-induced platelet aggregation. Among them, 141-gingerdione (I8) and 51-gingerdione (19) showed the highest potency, being about 1/3 and one time as potent as indomethacin, respectively. Preliminary studies indicated that the mechanism of action of these gingerdione derivatives differed from indomethacin. Unlike indomethacin, they showed no appreciable COX-I and COX-2 inhibition. The exact mechanism of action of these new compounds\",\"PeriodicalId\":22409,\"journal\":{\"name\":\"The Chinese Pharmaceutical Journal\",\"volume\":\"55 1\",\"pages\":\"259-269\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Chinese Pharmaceutical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7019/CPJ.200208.0259\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Chinese Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7019/CPJ.200208.0259","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

为了寻找新的抗血小板药物,天然存在的姜二酮(20,24)被选为先导化合物。合成了一系列衍生物,并对其抗血小板活性进行了筛选。结果表明,所有合成的姜二酮衍生物对aa诱导的血小板聚集均有明显的抑制作用。其中,141-姜二酮(I8)和51-姜二酮(19)的效价最高,分别约为吲哚美辛的1/3和1倍。初步研究表明,这些姜二酮衍生物的作用机制与吲哚美辛不同。与吲哚美辛不同,它们没有明显的cox - 1和COX-2抑制作用。这些新化合物的确切作用机制
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Synthesis of Gingerdione Derivatives as Potent Antiplatelet Agents
In search of novel antiplatelet agents, the naturally-occurring gingerdiones (20, 24) were selected as lead com pounds. A series of their derivatives were synthesized and screened for anti-platelet activity. It was found that all of the synthesized gingerdione derivatives demonstrated potent inhibition against AA-induced platelet aggregation. Among them, 141-gingerdione (I8) and 51-gingerdione (19) showed the highest potency, being about 1/3 and one time as potent as indomethacin, respectively. Preliminary studies indicated that the mechanism of action of these gingerdione derivatives differed from indomethacin. Unlike indomethacin, they showed no appreciable COX-I and COX-2 inhibition. The exact mechanism of action of these new compounds
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Research Progress of Pharmacokinetic Interactions between Lopinavir/Ritonavir and Statins Results and Discussion on National Vaccine Proficiency Testing Schemes in 2020 Case Study of Icotinib on The Impact of Domestic Innovative Drugs Timely Covered by Medical Insurance Evaluation of α-Interferon Applied in COVID-19 Therapy Regimen Detection and Analysis of Safety Signals of Chloroquine Based Upon FDA Adverse Event Database
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1